A new setpoint for immunometabolism Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease. Rheos was founded by Third Rock Ventures and is located in Cambridge, MA.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/rheos-medicines-inc” connections=”true” suffix=””]
Rheos through integration of Çomics data sets _ including DNA sequencing, transcriptional, metabolomic profiling and incorporating primary patient samples, build insights that are specific to human disease.
In Mar 2018, Third Rock Ventures Launches Rheos Medicines with $60 Mn in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases.